Pfizer manufacturing problems leave nonprofits paying exorbitant prices for dwindling supplies of life-saving naloxone.
As the United States faces an unprecedented surge in opioid overdoses, harm reduction groups are seeing shortages in naloxone, a usually affordable and easy-to-use medication that reverses overdoses and has been credited with saving many lives.
But it’s not because of a lack of supply; there’s actually plenty of naloxone out there. Instead, the dangerous shortage of naloxone is all about soaring prices.
Community groups working to prevent overdose deaths are now paying up to 30 times more for the life-saving medication – at a time when more Americans than ever are dying from overdoses. Read more at the Guardian.
I was also interviewed about this story on WNYC’s The Takeaway.
Categories: Freelance Articles